http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006027628-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd7f7139d3dab5f0bfed2d70c3a50cbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38983c2a881cecde6b06c6ee9aac7e76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3316e7eaad6afd702869bcc58f8067e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1de66842165a7e659b09fec5d0b1f975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5196b6579cf1aa5b48df7ef618953769
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1581828aa6e2b02a0c480c7d2bb7eed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e668a9a0f0d8fa8c32c51b00add8cc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82ad2ec2f0966dd0f70d4d7546931fb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e7aa16d9dd577f0d7a1125bcbc5a13f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_585e5bfb6d7d77b570f21a7bf3857237
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06
filingDate 2005-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1703628d8b4e55ee5510e10c3d2e874
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79ef324ab99d995f644233e8493ac952
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0851cdaf5b3768ad7cb53c56da3d1f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd7b3e276d93f8b6c40da58746ca9cf5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_452a64fac27c235d497e57d7c9b2b57d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec0fe5a86fc185118bdfa6b1a7515788
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_763722ce59829d1a1548721716326178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3b20c95b8b45d7dfafc84aeaee4ee86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5798d503eb3b22de44cd5e67b6cfe9ca
publicationDate 2006-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006027628-A3
titleOfInvention Naphthalimide derivatives as antiviral agents
abstract The present invention relates to the use of naphthalimide compounds of formula (I), wherein A, B, R1, R2, n and Ra are defined herein, and pharmaceutically acceptable salts thereof, for the treatment or prevention of infection by hepatitis C virus.
priorityDate 2004-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03101998-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5235045-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0733365-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0031039-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0055118-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0930883-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5789434-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439534
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11513929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66491

Total number of triples: 72.